78 related articles for article (PubMed ID: 10533765)
1. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
Ohlin B; Cederberg A; Forssell H; Solhaug JH; Tveit E
Eur J Surg; 1999 Sep; 165(9):875-84. PubMed ID: 10533765
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
Malangoni MA; Song J; Herrington J; Choudhri S; Pertel P
Ann Surg; 2006 Aug; 244(2):204-11. PubMed ID: 16858182
[TBL] [Abstract][Full Text] [Related]
3. Multicenter, double-blind, randomized, phase II trial to assess the safety and efficacy of ceftolozane-tazobactam plus metronidazole compared with meropenem in adult patients with complicated intra-abdominal infections.
Lucasti C; Hershberger E; Miller B; Yankelev S; Steenbergen J; Friedland I; Solomkin J
Antimicrob Agents Chemother; 2014 Sep; 58(9):5350-7. PubMed ID: 24982069
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
D'Angelica MI; Ellis RJ; Liu JB; Brajcich BC; Gönen M; Thompson VM; Cohen ME; Seo SK; Zabor EC; Babicky ML; Bentrem DJ; Behrman SW; Bertens KA; Celinski SA; Chan CHF; Dillhoff M; Dixon MEB; Fernandez-Del Castillo C; Gholami S; House MG; Karanicolas PJ; Lavu H; Maithel SK; McAuliffe JC; Ott MJ; Reames BN; Sanford DE; Sarpel U; Scaife CL; Serrano PE; Smith T; Snyder RA; Talamonti MS; Weber SM; Yopp AC; Pitt HA; Ko CY
JAMA; 2023 May; 329(18):1579-1588. PubMed ID: 37078771
[TBL] [Abstract][Full Text] [Related]
5. Optimal timing for antimicrobial prophylaxis to reduce surgical site infections: a retrospective analysis of 531 patients.
Paasch C; Schildberg C; Lünse S; Heisler S; Meyer J; Kirbach J; Kobelt E; Hunger R; Haller IE; Helmke C; Mantke R
Sci Rep; 2023 Jun; 13(1):9405. PubMed ID: 37296185
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States.
Prabhu VS; Solomkin JS; Medic G; Foo J; Borse RH; Kauf T; Miller B; Sen SS; Basu A
Antimicrob Resist Infect Control; 2017; 6():107. PubMed ID: 29090091
[TBL] [Abstract][Full Text] [Related]
7. Observation on the Curative Effect of Different Anti-infective Treatment Regimens for Children with Acute Appendicitis.
Zhang Y; Sha S; Liu W; Zou L; Shi X; Ma S; Tao J
Altern Ther Health Med; 2024 May; ():. PubMed ID: 38814611
[TBL] [Abstract][Full Text] [Related]
8. Safety of Metronidazole in Late Pre-term and Term Infants with Complicated Intra-abdominal Infections.
Commander SJ; Gao J; Zinkhan EK; Heresi G; Courtney SE; Lavery AP; Delmore P; Sokol GM; Moya F; Benjamin D; Bumpass TG; Debski J; Erinjeri J; Sharma G; Tracy ET; Smith PB; Cohen-Wolkowiez M; Hornik CP;
Pediatr Infect Dis J; 2020 Sep; 39(9):e245-e248. PubMed ID: 32453198
[TBL] [Abstract][Full Text] [Related]
9. Clinical and microbiological characteristics of Ruminococcus gnavus bacteremia and intra-abdominal infection.
Watanabe N; Watari T; Otsuka Y; Hosokawa N; Yamagata K; Fujioka M
Anaerobe; 2024 Feb; 85():102818. PubMed ID: 38211774
[TBL] [Abstract][Full Text] [Related]
10. Comment on hydration with Cefuroxime-a method for sealing a small leaking corneal perforation.
Aslankurt M; Çekiç O
Int J Ophthalmol; 2017; 10(4):663-664. PubMed ID: 28503446
[No Abstract] [Full Text] [Related]
11. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections.
Cohn SM; Lipsett PA; Buchman TG; Cheadle WG; Milsom JW; O'Marro S; Yellin AE; Jungerwirth S; Rochefort EV; Haverstock DC; Kowalsky SF
Ann Surg; 2000 Aug; 232(2):254-62. PubMed ID: 10903605
[TBL] [Abstract][Full Text] [Related]
12. Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
Namias N; Solomkin JS; Jensen EH; Tomassini JE; Abramson MA
Surg Infect (Larchmt); 2007 Feb; 8(1):15-28. PubMed ID: 17381394
[TBL] [Abstract][Full Text] [Related]
13. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
Solomkin JS; Yellin AE; Rotstein OD; Christou NV; Dellinger EP; Tellado JM; Malafaia O; Fernandez A; Choe KA; Carides A; Satishchandran V; Teppler H;
Ann Surg; 2003 Feb; 237(2):235-45. PubMed ID: 12560782
[TBL] [Abstract][Full Text] [Related]
14. Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery.
Maltezou HC; Nikolaidis P; Lebesii E; Dimitriou L; Androulakakis E; Kafetzis DA
Eur J Clin Microbiol Infect Dis; 2001 Sep; 20(9):643-6. PubMed ID: 11714046
[TBL] [Abstract][Full Text] [Related]
15. Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla
Hubbard ATM; Mason J; Roberts P; Parry CM; Corless C; van Aartsen J; Howard A; Bulgasim I; Fraser AJ; Adams ER; Roberts AP; Edwards T
Nat Commun; 2020 Oct; 11(1):4915. PubMed ID: 33004811
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluating the appropriate use of piperacillin /tazobactam in cardiac center of a tertiary care hospital.
Mekdad SS; AlSayed L
J Cardiothorac Surg; 2020 May; 15(1):70. PubMed ID: 32357895
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Susceptibility of Microorganisms Isolated from Patients with Intraabdominal Infection in Korea: a Multicenter Study.
Yoon YK; Kim J; Moon C; Lee MS; Hur J; Lee H; Kim SW
J Korean Med Sci; 2019 Dec; 34(47):e309. PubMed ID: 31808326
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
